VP, Global Medical Affairs at Zai Lab (US) LLC | CA, US | Rezi

VP, Global Medical Affairs at Zai Lab (US) LLC

VP, Global Medical Affairs

Zai Lab (US) LLC · CA, US

3 weeks ago

VP, Global Medical Affairs

Zai Lab (US) LLC · CA, US

22 days ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now
Resume preview

Tailor your resume to this VP, Global Medical Affairs role.

Rezi rewrites your resume against Zai Lab (US) LLC's job description. Free.

Resume score gauge reading 58 out of 100

Don't guess if your resume is good enough.

See how it scores against the VP, Global Medical Affairs posting at Zai Lab (US) LLC — free, in seconds.

About the Role

The VP, Global Medical Affairs will build and lead Zai Lab's Global Medical Affairs organization, with primary emphasis on the US and other regions outside China. This leader will establish the vision, strategy, organizational capabilities, and operating infrastructure required to support the company's first global launch and expanding pipeline. The role will serve as the senior Medical Affairs leader for global programs across the oncology and immunology portfolio, driving scientific leadership, evidence generation, external engagement, and cross-functional collaboration to maximize the value of Zai Lab's medicines throughout their lifecycle.

Responsibilities

  • Define and own the Medical Affairs strategy for Zai Lab's global oncology and immunology portfolio, providing leadership for global medical priorities, scientific engagement, and evidence generation.
  • Foster strong partnership with Medical Affairs leadership in China to ensure a coordinated and aligned approach to global programs.
  • Provide executive-level scientific leadership and represent Medical Affairs across internal governance bodies, executive leadership forums, and cross-functional decision-making processes.
  • Ensure all medical affairs activities comply with applicable regulations, industry standards (PhRMA, OIG), and internal policies.
  • Lead development and continuous improvement of Medical Affairs SOPs and governance frameworks.
  • Oversee Medical Information operations and respond to escalated medical inquiries.
  • Develop and execute comprehensive pre-launch Medical Affairs plans for global pipeline assets in the US and other regions outside China, establishing the scientific and clinical foundation ahead of commercial launch.
  • Partner with Regulatory Affairs on US label development, lifecycle management, and Health Authority interactions, including FDA advisory committees and scientific advice meetings.
  • Lead KOL identification, mapping, and engagement strategies across key oncology centers and academic institutions.
  • Establish peer-level relationships with thought leaders in SCLC, neuroendocrine carcinomas, and other priority indications.
  • Partner with Commercial and Market Access teams to ensure scientific communication readiness, payer evidence packages, and HEOR alignment as commercial infrastructure is built out.
  • Develop and oversee evidence generation plans across the US and other regions outside China, including IIS programs, real-world evidence (RWE) initiatives, and collaborative research studies.
  • Lead the publication strategy and oversight for global Medical Affairs programs, ensuring high-quality, timely dissemination of clinical data at key oncology congresses and in peer-reviewed journals.
  • Oversee the development of scientific communication materials, medical education content, and advisory board programs.
  • Champion competitive intelligence and landscape analysis, translating insights into actionable medical strategy.
  • Engage key oncology cooperative groups, professional societies, and academic networks to advance disease education and support Zai Lab’s scientific reputation.
  • Own the patient advocacy strategy for the US and other regions outside China.
  • Build relationships with relevant patient advocacy organizations, integrate patient perspectives into medical strategy, and support disease awareness and education initiatives.
  • Represent Zai Lab at national and international medical congresses, scientific symposia, and regulatory interactions.
  • Build and lead a high-performing Medical Affairs team supporting the US and other regions outside China.
  • Partner closely with Medical Affairs leadership in China on global programs and cross-regional coordination.
  • Recruit, develop, and retain top scientific talent, establishing clear accountability, performance metrics, and development plans.
  • Foster a culture of scientific rigor, patient-centricity, and integrity.
  • Oversee departmental budget planning, resource allocation, and agency/vendor governance to ensure operational excellence.

Requirements

  • MD with 12 years of progressive experience in medical affairs within the biopharmaceutical industry.
  • Clinical background in oncology or hematology.
  • Experience in precision oncology, ADCs, or immuno-oncology.
  • Existing KOL network in SCLC, lung cancers, or neuroendocrine carcinomas.
  • Demonstrated track record of building and leading global or US medical affairs organizations, including pre-launch, launch, and in-line medical support for oncology or specialty assets.
  • Proven ability to partner cross-functionally with Commercial, Market Access, Regulatory, and Clinical Development.
  • Deep expertise in US and global medical affairs operations: MSL programs, evidence generation, publication planning, medical education, advisory boards, and medical information.
  • Proven pre-launch and launch medical affairs leadership, including HEOR and market access medical strategy integration.
  • Experience in a global US/China operating environment or cross-border clinical and regulatory programs is a plus.
  • Entrepreneurial mindset with demonstrated success building medical affairs organizations in high-growth, pre-commercial or early commercial US biotech settings.
  • Strong scientific acumen with the ability to translate complex clinical data into compelling medical narratives.
  • Excellent communication and executive presence, comfortable engaging KOLs, health authorities, and C-suite stakeholders.
  • Ability to work across several time zones and travel internationally.
  • Experience in cross-regional collaboration including Asia/China.
  • Maintains the highest standards of integrity and ethics.

Skills

  • Medical Affairs Strategy
  • Organizational Leadership
  • Scientific Leadership
  • Evidence Generation
  • External Engagement
  • Cross-functional Collaboration
  • Regulatory Compliance
  • SOP Development
  • Medical Information
  • Pre-Launch Planning
  • Launch Readiness
  • KOL Engagement
  • Publication Strategy
  • Scientific Communication
  • Patient Advocacy
  • Budget Planning
  • Resource Allocation
  • Vendor Governance
  • Oncology
  • Immunology
  • Precision Oncology
  • ADCs
  • Immuno-oncology
  • SCLC
  • Neuroendocrine Carcinomas
  • HEOR
  • Market Access
  • Competitive Intelligence
  • Landscape Analysis

Location

  • South San Francisco, CA

Work Type

  • Full-time

Experience Level

  • VP Level
  • 12 years of progressive experience

Education Level

  • MD

Salary/Compensations

  • $369K - $536K/year

Benefits

  • Sign-on bonus
  • Restricted stock units
  • Discretionary awards
  • Full range of medical benefits
  • Financial benefits
  • 401(k) eligibility
  • Various paid time off benefits (vacation, sick time, parental leave)

About the Company

  • Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world.
  • The company's goal is to leverage its competencies and resources to positively impact human health worldwide.
  • Founded in 2014, Zai Lab has secured partnerships with leading global biopharmaceutical companies, generating a broad and late-stage pipeline of innovative drug candidates.
  • Zai Lab has earned the reputation as a trusted partner of choice for global biopharmaceutical companies seeking to access the Chinese market and find a long-term strategic partner for global clinical development.
  • The company's unique business model builds on in-licensed assets and innovative partnerships to expand internal discovery and development capabilities, creating a portfolio of potential best-in-class and/or first-in-class therapies.
  • Zai Lab currently has four products on the market in China.
  • Zai Lab was successfully listed on the Nasdaq Stock Market in September 2017 and completed secondary listing on Hong Kong Stock Exchange in September 2020.
  • In 2021, Zai Lab established its U.S. Headquarters in Cambridge, Massachusetts.
  • As of January 2022, the Company has a global team of approximately 2000 employees.
  • Zai Lab is proud of the gender diversity of its company and its promotion of women in biotech.
  • The company has achieved gender base pay equity at all levels.
  • 59% of Zai Lab's employees are women and 53% of its management positions are held by women.
  • Zai Lab is committed to the health of patients and the planet.
  • The company's environmental protection, social responsibility, and corporate governance strategy, called “Trust for Life,” is integrated within its business.

Equal Opportunity

  • All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, sexual orientation, gender identity, national origin, protected veteran status, or based on disability.